$1.19
0.01991.7%
最終更新: Oct 22, 10:38 AM
$1.20
0.032.56%
Benzinga
Benzinga
Benzinga
木曜日, 10 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Cardiol Therapeutics (CRDL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.07 | $-0.09 | $-0.09 |
| Actual | $-0.04 | $-0.07 | $-0.05 | $-0.09 |
| Surprise | +60.0% | 0.00% | +44.4% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.06 | $-0.06 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.04 | $-0.09 | 60.0 % |
| Q1 | May 11, 2026 | $-0.07 | $-0.07 | 0.00 % |
| Q4 | Mar 31, 2026 | $-0.05 | $-0.09 | 44.4 % |
| Q3 | Nov 13, 2025 | $-0.09 | $-0.09 | 0.00 % |